BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30101696)

  • 1. Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive Review.
    Ghassami E; Varshosaz J; Taymouri S
    Curr Pharm Des; 2018; 24(28):3303-3319. PubMed ID: 30101696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Outlook of Synthetic Strategies and Applications of Redox-Responsive Nanogels in Drug Delivery.
    Kumar P; Liu B; Behl G
    Macromol Biosci; 2019 Aug; 19(8):e1900071. PubMed ID: 31298803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
    Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
    Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-sensitive shell-crosslinked polypeptide-block-polysaccharide micelles for efficient intracellular anticancer drug delivery.
    Zhang A; Zhang Z; Shi F; Xiao C; Ding J; Zhuang X; He C; Chen L; Chen X
    Macromol Biosci; 2013 Sep; 13(9):1249-58. PubMed ID: 23840011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy.
    Sun H; Meng F; Cheng R; Deng C; Zhong Z
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1109-22. PubMed ID: 23517599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in redox-responsive drug delivery systems of tumor microenvironment.
    Guo X; Cheng Y; Zhao X; Luo Y; Chen J; Yuan WE
    J Nanobiotechnology; 2018 Sep; 16(1):74. PubMed ID: 30243297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of polysaccharides grafted on nanoparticles investigated by EPR.
    Bertholon I; Hommel H; Labarre D; Vauthier C
    Langmuir; 2006 Jun; 22(12):5485-90. PubMed ID: 16732681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH- and redox-responsive polysaccharide-based microcapsules with autofluorescence for biomedical applications.
    Gao L; Fei J; Zhao J; Cui W; Cui Y; Li J
    Chemistry; 2012 Mar; 18(11):3185-92. PubMed ID: 22344618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.